Skip to main content Accessibility help
×
×
Home

Urinary incontinence and diarrhoea associated with the switch from oral to injectable risperidone

  • Enrica Di Rosa (a1) (a2), Daniela Caldirola (a2), Achille Motta (a2) and Giampaolo Perna (a2) (a3) (a4)

Abstract

Objective

Urgency, urinary incontinence and bowel disturbances are distressing side effects that have been observed during treatment with risperidone and other antipsychotics probably due to the receptor affinity profile. This occurrence can lead to poor compliance and therefore impair clinical outcome.

Method

We report the case of a 50 year‐old lady, who experienced urinary incontinence and diarrhoea, when switching from oral to injectable risperidone, which ceased when discontinuing the drug.

Results and conclusions

It should be taken into account that some side effects can be revealed when switching from oral to depot formulations due to non‐compliance to orals; nevertheless dose‐dependent mechanisms and individual metabolic variability must be considered when observing idiosyncratic reactions to drugs.

Copyright

Corresponding author

Enrica Di Rosa, Department of Clinical and Experimental Medicine and Pharmacology, University of Messina, Policlinico Universitario, via Consolare Valeria, Messina 198125, Italy. Tel: +00393333992601; Fax: +0039090695136; E‐mail: edirosa@unime.it, enricadirosa@tiscali.it

References

Hide All
1Sahoo, S, Manoj, K. Antipsychotic‐induced urinary dysfunction: anticholinergic effect or otherwise? BMJ Case Rep 2009. DOI: bcr02.2009.1547.
2Ambrosini, PJ. A pharmacological paradigm for urinary incontinence and enuresis. J Clin Psychopharmacol 1984;4:247253.
3Ambrosini, PJ, Nurnberg, HG. Urinary incontinence and neuroleptics. Am J Psychiatry 1982;139:539.
4Sagar, R, Varghese, ST, Balhara, YP. Olanzapine‐induced double incontinence. Indian J Med Sci 2005;59:163164.
5Benazzi, F. Urinary retention with fluoxetine–haloperidol combination in a young patient. Can J Psychiatry 1996;41:606607.
6Kiruluta, HG, Andrews, K. Urinary incontinence secondary to drugs. Urology 1983;22:8890.
7Myung‐Ji, L, Chul‐Eung, K. Use of aripiprazole in clozapine induced enuresis: report of two cases. J Korean Med Sci 2010;25:333335.
8Herguner, S, Mukaddes, NM. Risperidone‐induced double incontinence. Prog Neuropsychopharmacol Biol Psychiatry 2008;32:10851086.
9Fraser, MO, Chancellor, MB. Neural control of the urethra and development of pharmacotherapy for stress urinary incontinence. BJU Int 2003;91:743748.
10Deeks, ED. Risperidone long‐acting injection in bipolar I disorder. Drugs 2010;70:1001.012.
11Vera, PL, Miranda‐Sousa, A, Nadelhaft, I. Effects of two atypical neuroleptics, olanzapine and risperidone, on the function of the urinary bladder and the external urethral sphincter in anesthetized rats. BMC Pharmacol 2001;1:4.
12Kirshner, A, Davis, RR. Priapism associated with the switch from oral to injectable risperidone. J Clin Psychopharmacol 2006;26:626628.
13Hendset, M, Molden, E, Refsum, H, Hermann, M. Impact of CYP2D6 genotype on steady‐state serum concentration of risperidone and 9 hydroxyrisperidone in patients using long‐acting injectable risperidone. J Clin Psychopharmacol 2009;29:537541.
14de Leon, J, Susce, MT, Pan, RM et al. The CYP2D6 poor metabolizer phenotype may be associated with risperidone adverse drug reactions and discontinuations. J Clin Psychiatry 2005;66:1527.
15Smith, EM, Iftikar, FI, Higgins, S et al. In vitro inhibition of cytochrome P450‐mediated reactions by gemfibrozil, erythromycin, ciprofloxacin and fluoxetine in fish liver microsomes. Aquat Toxicol 2012;109:259266.
16Desta, Z, Kerbusch, T, Flockhart, DA. Effect of clarithromycin on the pharmacokinetics and pharmacodynamics of pimozide in healthy poor and extensive metabolizers of cytochrome P450 2D6 (CYP2D6). Clin Pharmacol Ther 1999;65:1020.
17Bruce, MA, Hall, SD, Haehner‐Daniels, BD et al. In vivo effect of clarithromycin on multiple cytochrome P450s. Drug Metab Dispos 2001;29:10231028.
18Hersh, EV, Moore, PA. Drug interactions in dentistry: the importance of knowing your CYPs. J Am Dent Assoc 2004;135:298311.
19Ishak, KJ, Tan, Y, Glass, J et al. Risk of discontinuation of risperidone after exposure to potentially interacting drugs: a nested case‐control study in patients with schizophrenia. Clin Ther 2008;30:1.
Recommend this journal

Email your librarian or administrator to recommend adding this journal to your organisation's collection.

Acta Neuropsychiatrica
  • ISSN: 0924-2708
  • EISSN: 1601-5215
  • URL: /core/journals/acta-neuropsychiatrica
Please enter your name
Please enter a valid email address
Who would you like to send this to? *
×

Keywords

Metrics

Altmetric attention score

Full text views

Total number of HTML views: 0
Total number of PDF views: 0 *
Loading metrics...

Abstract views

Total abstract views: 0 *
Loading metrics...

* Views captured on Cambridge Core between <date>. This data will be updated every 24 hours.

Usage data cannot currently be displayed